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The terms ‘haploid’ and ‘diploid’ that 
describe single (n) and double (2n) 
chromosome sets in cells were coined 
by the Polish-German botanist Eduard 
Strasburger and originate from the 
Greek terms haplóos meaning ‘single’ 
and diplóos meaning ‘double’. The term 
‘ploidy’ was subsequently derived to 
describe the total chromosome content 
of cells. Consequently, the term ‘euploid’ 
refers to a chromosome complement 
that is an exact multiple of the haploid 
number. Therefore, haploids and diploids 
are both cases of normal euploidy. 
Euploid types that have more than two 
sets of chromosomes are ‘polyploid’ 
such as ‘triploid’ (3n), ‘tetraploid’ (4n), 
‘pentaploid’ (5n), and so forth. There 
are various natural euploid states with 
some organisms existing as haploids 
(fungi), diploids (most mammals), and 
polyploids (plants).
Cells rely on precise mechanisms 
to ensure accurate chromosome 
segregation during mitosis and meiosis to 
maintain their euploid state. Errors in the 
faithful execution of these mechanisms 
cause chromosome mis-segregation 
resulting in the generation of ‘aneuploid’ 
(i.e. ‘not euploid’) daughter cells. 
Aneuploidy is defined as a chromosome 
number that deviates from a multiple of 
the haploid set, and it is associated with 
abnormalities in cell function, such as in 
cancer and in organismal development 
such as in Down syndrome and mosaic 
variegated aneuploidy (MVA) (Figure 1). 
Aneuploidy reflects both gains/losses 
of whole chromosomes, leading to 
‘whole chromosomal’ aneuploidy, as 
well as non-balanced rearrangements 
of chromosomes, including deletions, 
amplifications or translocations of large 
regions of the genome resulting in 
‘structural’ aneuploidy. Here, we discuss 
the causes of aneuploidy (Figure 2) and 
the consequences of aneuploidy on cells 
and organisms.
The causes of whole chromosomal 
aneuploidy
During cell division, duplicated 
chromosomes must be segregated 
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to prevent aneuploidy. Faithful 
chromosome segregation relies on 
the organization of microtubules into 
a bipolar mitotic spindle structure, the 
proper attachment of chromosomes to 
spindle microtubules at kinetochores 
(specialized proteinaceous structures 
that assemble on each chromosome), 
and an appropriate length of time in 
mitosis to ensure that all chromosomes 
correctly attach to spindle microtubules. 
Spindle assembly checkpoint defects
The spindle assembly checkpoint 
(SAC) is a highly regulated signaling 
network that promotes chromosome 
segregation fidelity by delaying mitotic 
progression until all kinetochores are 
attached to spindle microtubules. In 
higher eukaryotes, the SAC is essential 
for cell and organismal viability since 
complete abrogation of SAC function 
leads to lethal levels of chromosome 
mis-segregation. However, weakening 
SAC function allows for premature 
cell-cycle progression to anaphase and 
dramatically increases the probability 
of whole chromosome mis-segregation 
leading to aneuploidy. 
Errors in kinetochore–microtubule 
attachment
For duplicated chromosomes to 
segregate accurately, sister kinetochores
must attach to microtubules emanating 
from opposing centrosomes/spindle 
poles, and this bi-oriented attachment 
is termed ‘amphitely’. However, the 
initial attachment of microtubules 
to kinetochores is stochastic and 
error prone. Erroneous attachments 
are corrected through repeated 
cycles of microtubule attachment 
and detachment at kinetochores, 
and SAC activity provides sufficient 
time for these corrections. However, 
improper kinetochore–microtubule 
(k-MT) attachments in which a single 
kinetochore is attached to both spindle 
poles (merotelic attachment) are not 
detected by the SAC, and if these 
are uncorrected by anaphase onset, 
the probability of chromosome mis-
segregation increases, resulting in whole
chromosome aneuploidy. Moreover, 
chromosomes with unresolved merotelic
attachments frequently get trapped in 
the cleavage furrow between dividing 
cells, leading to chromosome breakage 
and structural aneuploidy.  29, 2015 ©2015 Elsevier Ltd All rights reservCohesion defects
Cohesion between sister chromatids 
is established during DNA replication 
through the deposition of a multi-subunit 
protein complex known as the cohesin 
complex. This molecular ‘glue’ holds 
the sister chromatids together until 
the SAC is satisfied, and subsequent 
proteolytic cleavage of cohesin allows 
for synchronous sister chromatid 
separation. Complete disruption of 
cohesion results in precocious sister 
chromatid separation and extensive 
chromosome mis-segregation. However, 
subtle defects in cohesion can disrupt 
centromere geometry by altering the 
normal back-to-back configuration of 
sister kinetochores. In principle, this 
would increase the formation rate of 
merotelic attachments and elevate 
chromosome mis-segregation rates. 
Supernumerary centrosomes
Centrosomes are responsible for 
nucleating microtubules and contribute 
to organizing microtubules into bipolar 
spindles. Consequently, the centrosome 
duplication cycle is tightly regulated to 
ensure that normal cells enter mitosis 
with only two centrosomes. Defects in 
the centrosome duplication cycle that 
cause centrosome over-duplication raise 
the probability of forming multipolar 
spindles, and chromosome segregation 
on multipolar spindles often leads to 
aneuploid daughter cells. Moreover, 
even transient multipolar spindles 
formed during mitosis greatly increase 
the formation rate of merotelic k-MT 
attachments, resulting in increased 
chromosome mis-segregation.
Tetraploidy
Tetraploid cells that are derived from 
diploid cells have extra centrosomes, 
which can lead to aneuploidy as 
described above. There are a number 
of events that lead to tetraploidy. 
For example, defective cytokinesis 
at the end of mitosis may lead to 
the formation of a single cell with 
duplicated chromosome content. 
Similarly, mitotic slippage (or leakage) 
occurs when cells arrest in mitosis 
and exit without SAC satisfaction. 
This culminates in a biochemically 
normal mitotic exit characterized by 
sister chromatid separation but without 
chromosome segregation into daughter 
cells, resulting in a tetraploid cell. 
Fusion of diploid cells also generates 
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Figure 1. Constitutional, somatic, and structural karyotypes.
(A) Spectral karyotype of a normal human diploid cell with 46 chromosomes (courtesy of National Human Genome Research Institute http://www.
genome.gov). (B) G-band karyotype of a female with Down syndrome illustrating constitutional aneuploidy. All cells in this individual have 47 chro-
mosomes with trisomy 21 (reprinted from Antonarakis et al. (2004) by permission from Macmillan Publishers Ltd: Nat. Rev. Genet. © 2004). (C) Two 
G-band karyotypes from an individual with mosaic variegated aneuploidy (MVA) demonstrating somatic aneuploidy. These lymphoblastoid cells 
have distinct whole chromosome losses and gains exemplifying the mosaic aneuploidies of MVA (reprinted from Hanks et al. (2004) by permission 
from Macmillan Publishers Ltd: Nat. Genet. © 2004). (D) Spectral karyotypes of glioblastoma-derived U251 cells. These cells are from the same 
culture but have unique whole chromosome and structural aneuploidies due to chromosomal instability (from Thompson and Compton (2011), 
with kind permission from Springer Science and Business Media).tetraploidy (and polyploidy). Cell 
fusion is a normal, programmed event 
that occurs in development, such 
as during fertilization or during the 
formation of multi-nucleate syncytial 
cells in the placenta, muscle fiber, or 
bone. However, in non-programmed 
fusion events, tetraploidy created by 
cell fusion may generate aneuploid 
progeny in subsequent divisions. 
Finally, tetraploidy can arise through 
endoreplication (or endoreduplication), 
which is defined as the replication of 
the nuclear genome in the absence of 
mitotic cell division. Telomere dysfunction 
Telomeres are specialized structures 
at the ends of linear chromosomes 
and telomere dysfunction has been 
associated with the generation 
of aneuploidy. In the absence of 
telomerase — the enzyme that 
synthesizes the DNA sequence at the 
end of chromosomes — chromosome 
ends become uncapped and exposed. 
Cells respond to this by activating 
the non-homologous end joining 
DNA repair pathway that results 
in telomeric fusion between two 
chromosomes creating a dicentric Current Biology 25, R523–R548, June 29, 201chromosome. Dicentric chromosomes 
are aberrant chromosomes that have 
two centromeres and therefore have 
a substantially higher probability of 
segregating into one daughter cell or 
being broken as they are stretched 
between two daughter cells.
The causes of structural aneuploidy
Structural aneuploidy is the 
consequence of DNA damage and/
or breakage resulting in non-balanced 
translocations, deletions and/
or duplications of large regions of 
chromosomes. Structural aneuploidy 5 ©2015 Elsevier Ltd All rights reserved R539
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Figure 2. Mechanisms that generate aneuploidy. 
Schematic representation of the cellular mechanisms that generate whole chromosomal aneu-
ploidy and structural aneuploidy, or both. Bi-directional arrows illustrate that structural aneuploidy 
may cause whole chromosome aneuploidy and vice versa, through dysregulation of cell signal-
ing pathways that are important for the maintenance of genomic stability. The same is true for 
the formation of merotelic k-MT attachments and the induction of tetraploidy. The formation of 
multipolar spindles during mitosis as a result of tetraploidy promotes the formation of merotelic 
k-MT attachments, which in turn causes whole chromosome mis-segregation, potentially leading 
to dysregulated centrosome duplication and tetraploidy.can occur through several mechanisms 
(Figure 2). In meiosis, misalignment of 
homologous chromosomes and unequal 
crossing over between non-sister 
chromatids often results in duplications 
of chromosome regions. Improper non-
allelic homologous recombination will 
cause DNA copy number variations due 
to deletions or duplications. Errors in 
DNA replication that remain unresolved 
in mitosis can cause acentric DNA 
fragments and chromatin bridges, 
resulting in chromosome breakage and 
structural aneuploidy. Also, incomplete 
DNA decatenation during mitosis results 
in chromosome breakage since it 
promotes the formation of DNA bridges. 
Finally, chromothripsis is a dramatic 
event that results in the pulverization 
of one or a few select chromosomes 
followed by their highly error-prone 
re-stitching. This leads to extensive 
chromosome rearrangements, which 
often include deletions, non-balanced 
translocations, duplications, and 
inversions. 
Aneuploidy in human conditions and 
diseases
Aneuploidy causes several human 
conditions and diseases including 
Down syndrome and mosaic variegated 
aneuploidy (MVA), and is associated 
with cancer (Figure 1). These disorders 
illustrate how aneuploidy can arise under 
different circumstances in an organism. 
Constitutional aneuploidy, prevalent in R540 Current Biology 25, R523–R548, Junconditions such as Down syndrome, 
typically arises through fertilization of an 
aneuploid gamete generated through 
defective chromosome segregation 
during meiosis. Somatic aneuploidy is 
acquired through defective chromosome 
segregation in mitosis and is 
characteristic of individuals with MVA and 
is found in over 90% of solid tumors. 
Down syndrome
Constitutional aneuploidy is mostly 
incompatible with normal fetal 
development. For example, in humans 
the only viable whole chromosome 
aneuploidies are trisomy 13, 18, or 
21. Individuals born with trisomy 13 
or 18 have severe developmental 
abnormalities and typically do 
not survive beyond the first year. 
Individuals with trisomy 21 have Down 
syndrome, the most common form 
of mental retardation and the most 
common constitutional aneuploidy 
occurring in approximately 1 in 750 
live births. Individuals with Down 
syndrome display phenotypic 
variability in disease presentation, but 
common characteristics include facial 
dysmorphology, cognitive impairment, 
and congenital heart defects. 
MVA
MVA is a very rare disease and is an 
example of somatic aneuploidy with 
only a subset of cells being aneuploid 
in an individual. Clinical features of the e 29, 2015 ©2015 Elsevier Ltd All rights reserveddisease include growth retardation, 
microcephaly, developmental delays, 
and a high incidence of childhood 
cancers. In individuals with MVA, 25% 
or more of their cells (occurring in 
multiple tissues) are aneuploid, with the 
aneuploid cells predominantly being 
monosomic or trisomic for multiple 
different chromosomes. A recent genetic 
study revealed the cause of MVA in one 
family to be bi-allelic germline mutations 
in the BUB1B gene (a component of the 
SAC). This suggests that a weakened 
SAC causes the mitotic errors that 
generate the mosaic aneuploidies.
Cancer
Cancer is the most common human 
disease characterized by somatic 
aneuploidy (both whole and structural) 
with over 90% of solid tumors estimated 
to be aneuploid. Like MVA, whole 
chromosomal aneuploid tumor cells 
are generated by errors in chromosome 
segregation during mitosis. Whole 
genome sequencing of cancers 
demonstrates a low frequency of 
mutations in genes encoding proteins 
with mitotic functions, indicating that 
altered expression of mitotic proteins 
may instead account for the prevalence 
of aneuploidy in tumors. 
The role of aneuploidy in tumor 
initiation, progression, and recurrence 
has been the subject of controversy for 
many years. At the beginning of the 19th 
century, Theodore Boveri observed multi-
polar mitoses in sea urchin embryos 
and proposed that a “certain abnormal 
chromosome constitution” caused 
malignant tumors. In contrast, others 
argued that aneuploidy is not required for 
tumor initiation or that it is a benign side 
effect of transformation. There was no 
molecular support for Boveri’s hypothesis 
until it was demonstrated that whole 
chromosome loss created a recessive 
condition that causes retinoblastoma. 
Recent work with mouse models has 
demonstrated that aneuploidy can have 
both a tumor-promoting and tumor-
suppressing influence depending on the 
tissue of origin.
Not only are many tumor cells 
aneuploid, but many also demonstrate 
chromosomal instability (CIN). While 
aneuploidy is the state of having an 
abnormal chromosome number, CIN is 
a persistent rate of whole chromosome 
mis-segregation that leads to random 
chromosome losses and/or gains. 
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aneuploid and stable or aneuploid and 
unstable with respect to chromosome 
complement. 
Many tumor karyotypes display 
structural aneuploidy in addition 
to whole chromosome aneuploidy. 
One mechanism to promote both 
numerical and structural changes is 
through chromothripsis, the complex 
rearrangement of one or a few select 
chromosomes after catastrophic 
shattering and error-prone re-stitching 
of the chromosome fragments. 
Chromothripsis occurs in approximately 
5% of cancers and has been detected 
in a variety of cancers, including 
glioblastoma, osteosarcoma, melanoma, 
leukemia, and small-cell lung, prostate, 
and colorectal cancers. 
Biochemical consequences of 
aneuploidy
Aneuploidy appears in normal tissues 
yet it is frequently associated with 
developmental abnormalities and 
diseases. In this section, we discuss 
the biochemical consequences of 
aneuploidy on cellular physiology.
Aneuploidy in normal tissues
Aneuploidy has been observed in 
some normal tissues, but whether it 
contributes to normal tissue function 
or arises somatically and is tolerated 
in those tissues remains unknown. 
Evidence from fluorescence in situ 
hybridization indicates that neurons can 
be aneuploid both during development 
and in adults. It is argued that aneuploid 
neurons provide genetically mosaic 
neural circuitries that play an integral 
part in the normal organization of the 
adult mammalian brain. However, this 
view remains controversial as single-
cell sequencing failed to demonstrate 
elevated levels of aneuploidy in 
neurons. Differences in ploidy have 
also been reported in hepatocytes. 
As many as 30–40% of cells in the 
adult human liver are polyploid and 
may alternate between aneuploid and 
polyploid states. It is hypothesized that 
increases in gene copy numbers are 
important for tolerance to genotoxic 
stress. Aneuploid cells have also been 
documented in early human embryos 
as soon as 3 days post-fertilization. Yet, 
most of these aneuploid cells appear 
to be out-competed in the blastocyst 
after the cleavage stage. The prevailing Chypothesis states that aneuploidy-
dependent effects on the dysregulation 
of cell-cycle checkpoints are important 
for rapid, albeit imprecise, cell division 
during early embryogenesis and that 
aneuploidy only becomes detrimental 
to the embryo at later stages of 
development. Finally, an association 
between aneuploidy and aging was 
reported more than four decades 
ago based on the observation that Y 
chromosome loss is correlated with 
increasing age. More recent studies 
have shown that aneuploidy increases 
with age in fibroblasts collected at 
successive time points from the 
same donors. Whether aneuploidy is 
a cause or a consequence of aging-
associated phenotypes is unknown 
but one possibility is that aneuploidy 
accelerates aging by impairing protein 
quality control pathways in cells. 
Proliferation defects
Constitutional aneuploidy is 
associated with poor growth. For 
example, experimentally generated 
stable aneuploid cells from a variety 
of organisms have proliferation 
defects relative to wild-type cells. 
Haploid budding yeast strains 
carrying an extra copy of a single 
chromosome proliferate more slowly 
than wild-type strains and mouse 
embryonic fibroblasts (MEFs) that are 
trisomic for a single chromosome also 
proliferate more slowly than diploid 
MEFs. Similarly, cells from Down 
syndrome individuals with trisomy 21 
proliferate slower than diploid human 
cells. In Down syndrome, this cell 
proliferation defect is proposed to 
contribute to a decreased cerebellum 
size and possibly to cognitive 
impairment. 
Somatically acquired aneuploidy also 
appears incompatible with cell viability. 
Diploid cells do not proliferate following 
a chromosome mis-segregation event 
and evidence suggests that aneuploidy 
induces a p53-dependent cell-cycle 
arrest when it arises in diploid cells. 
Tumor cells are the exception to this 
rule as more than 90% of solid tumors 
are aneuploid. Thus, tumor cells have 
overcome this proliferation barrier, 
partly through mutations that modify 
the p53 and/or proteasome-mediated 
degradation pathways. These acquired 
mutations allow tumor cells to tolerate 
an aneuploid state.urrent Biology 25, R523–R548, June 29, 2015 Gene dosage sensitivity
In aneuploid budding yeast, transcription 
and translation scale with chromosome 
copy number such that the majority 
of genes on an extra chromosome are 
expressed at 1.5–2-fold higher levels. 
Studies in mouse models of Down 
syndrome and from individuals with 
Down syndrome have also confirmed 
that transcription levels for most genes 
scale with chromosome copy number. 
Theoretically, the increased expression 
of a particular gene or genes could 
cause specific phenotypes; however, 
there are only a few known examples 
of dosage-sensitive genes that cause 
lethality or decrease cellular fitness. 
Further, there is no known example 
of a single gene on chromosome 21 
with elevated expression that causes 
a Down syndrome phenotype. Another 
manifestation of dosage sensitivity is the 
possible allelic ratios and combinations 
that are only present in aneuploid cells. 
For example, errors in meiosis I can 
lead to heterotrisomy in individuals 
with Down syndrome. In cases of 
heterotrisomy, cells will have alleles from 
three different grandparents, a scenario 
that is impossible in a diploid state.
In contrast to Down syndrome and 
yeast strains carrying a single extra 
chromosome, aneuploid karyotypes in 
cancer can display far greater variability. 
Aneuploid cells derived from solid 
tumors often have multiple chromosome 
gains/losses and chromosome copy 
numbers vary widely for any given 
chromosome. Moreover, the tumor 
karyotype is often variable and unstable 
because tumor cells have a CIN 
phenotype. In addition, chromothripsis 
can generate high copy number 
alterations through the formation of 
double minutes: extra-chromosomal 
circular DNA segments that can amplify 
genes hundreds of times. Assuming 
that transcription and translation scale 
with copy number, gene expression in 
cancer cells would be expected to be 
far more dysregulated when compared 
with stable aneuploid yeast strains or 
Down syndrome cells and this likely 
contributes to disease.
Aneuploidy-induced stress 
phenotypes
Since transcription and translation 
tend to scale with chromosome copy 
number, it has been proposed that 
aneuploidy induces simultaneous ©2015 Elsevier Ltd All rights reserved R541
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perhaps all, genes encoded on the 
aneusomic chromosome, leading to a 
cellular stress response and decreased 
cellular fitness. For example, aneuploid 
budding yeast display gene expression 
signatures similar to the environmental 
stress response signatures in yeast. In 
addition, aneuploid yeast strains and 
trisomic MEFs have altered metabolic 
patterns compared with wild-type cells. 
For example, trisomic MEFs have an 
increased rate of glutamine consumption 
and aneuploid yeast strains have 
increased glucose uptake and increased 
levels of reactive oxygen species. 
Consequently, aneuploid yeast strains 
and trisomic MEFs display a proteotoxic 
stress phenotype. The increased level of 
proteins produced from the aneusomic 
chromosome places an extra burden 
on cellular protein quality control 
pathways that preserve homeostasis. 
This is of particular importance with 
regards to the maintenance of the 
correct stoichiometry of macromolecular 
complexes, whose subunits may 
be encoded by genes on different 
chromosomes. In agreement with 
this idea, aneuploid yeast strains and 
trisomic MEFs are sensitive to chemical 
compounds that exacerbate proteotoxic 
stress, such as protein folding inhibitors. 
Lastly, aneuploidy in budding yeast has 
been shown to facilitate further genomic 
instability due to elevated rates of 
chromosome loss and defects in DNA 
damage repair pathways.
Drug resistance and adaptation
Under normal growth conditions, 
aneuploid yeast strains proliferate more 
slowly than wild-type control cells. 
However, under conditions of stress, 
some aneuploid yeast strains show an 
enhanced proliferation rate in comparison 
with wild-type strains, suggesting that 
aneuploidy can generate phenotypic 
variation that provides a growth 
advantage under selective conditions. 
Alternatively, the sensitization to stress 
observed in aneuploid cells may render 
them more tolerant to further stressors. 
The phenotypic heterogeneity resulting 
from aneuploid karyotypes may also 
contribute to drug resistance and 
adaptability. In budding yeast and in 
human tumors it has been proposed that 
the phenotypic heterogeneity arising from 
a diverse population of aneuploid cells 
contributes directly to drug resistance.R542 Current Biology 25, R523–R548, JuneTherapeutic targeting of aneuploidy
The development of treatments 
that improve aneuploidy-induced 
phenotypes is particularly relevant 
to individuals with constitutional 
aneuploidy. For example, an in vitro 
cell culture method that exploits a 
natural form of dosage compensation 
was developed to silence one copy 
of chromosome 21 in cells from 
individuals with Down syndrome. 
Silencing of one copy of chromosome 
21 returned trisomic cells to a diploid 
state with only two active copies. Under 
these conditions, cell proliferation and 
neural progenitor formation increased, 
demonstrating that silencing a copy of 
chromosome 21 ameliorates some of 
the Down syndrome phenotypes. 
Alternatively, the selective killing 
of aneuploid cells relative to diploid 
cells is a potential therapeutic strategy 
for cancer treatment. The aneuploidy 
stress-induced phenotypes distinguish 
aneuploid cells from diploid cells, and 
this could be exploited to selectively 
eliminate aneuploid tumor cells. In 
support of this idea, energy and 
proteotoxic stress-inducing chemical 
compounds are lethal for trisomic MEFs 
but euploid cells are less sensitive. 
Additional strategies exploit the 
adaptability of aneuploid cells by 
applying an evolutionary trap, which 
involves subjecting aneuploid cells to 
sequential stress treatments such that 
the first treatment selects for a drug-
resistant population creating a more 
karyotypic homogenous population. 
The second treatment then targets 
and kills the dominant remaining 
karyotype.
Concluding remarks
There has been substantial progress 
in our understanding of the causes 
and consequences of aneuploidy. 
The paradox that aneuploidy tends 
to disrupt normal cell physiology but 
that it is commonly observed in solid 
tumors suggests that we are far from a 
complete understanding of the impact 
of aneuploidy on cellular physiology. 
This is further complicated by evidence 
showing tissue- and model-specific 
influences of aneuploidy. Despite 
these limitations, the design of novel 
strategies that specifically target 
aneuploid cells holds great promise 
for the treatment of diseases, such as 
Down syndrome and cancer, which  29, 2015 ©2015 Elsevier Ltd All rights reservedhave the potential to directly impact our 
social and economic networks. 
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